Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Assets (2016 - 2025)

Amphastar Pharmaceuticals has reported Return on Assets over the past 12 years, most recently at 0.08% for Q4 2025.

  • Quarterly results put Return on Assets at 0.08% for Q4 2025, down 3.0% from a year ago — trailing twelve months through Dec 2025 was 0.08% (down 3.0% YoY), and the annual figure for FY2025 was 0.08%, down 2.0%.
  • Return on Assets for Q4 2025 was 0.08% at Amphastar Pharmaceuticals, up from 0.07% in the prior quarter.
  • Over the last five years, Return on Assets for AMPH hit a ceiling of 0.13% in Q2 2022 and a floor of 0.05% in Q4 2022.
  • Median Return on Assets over the past 5 years was 0.04% (2021), compared with a mean of 0.04%.
  • Biggest five-year swings in Return on Assets: decreased -17bps in 2023 and later grew 13bps in 2024.
  • Amphastar Pharmaceuticals' Return on Assets stood at 0.1% in 2021, then crashed by -146bps to 0.05% in 2022, then surged by 41bps to 0.03% in 2023, then soared by 482bps to 0.11% in 2024, then fell by -24bps to 0.08% in 2025.
  • The last three reported values for Return on Assets were 0.08% (Q4 2025), 0.07% (Q3 2025), and 0.09% (Q2 2025) per Business Quant data.